title: Multiple agents rescue PC12 cells from serum-free cell death by translation- and transcription-independent mechanisms.
abstract: Past studies revealed that NGF and fibroblast growth factor (FGF) prevent the death of PC 12 pheochromocytoma cells that otherwise occurs in serum-free medium. Additional agents were tested here for their abilities to promote long-term survival of naive and NGF-pretreated (primed) PC 12 cells in serum-free conditions. Forskolin and permeant cAMP analogs effectively prevented serum-free cell death, as did micromolar levels of insulin and 10-100-nM levels of insulin-like growth factors I and II. In contrast to NGF and FGF, none of these agents caused neuronal differentiation of naive cells or neurite regeneration by primed cells. Each of the agents also prevented rapid cell death in a balanced salt solution, thus apparently ruling out a mechanism dependent on regulation of nutrient uptake. Epidermal growth factor and elevated K+ appeared to slow the rate of cell death, but did not promote long-term survival; phorbol ester, dexamethasone, or vanadate did not prevent cell death. Each of the survival-promoting agents was effective even when macromolecular synthesis was blocked. Because the synthesis inhibitors themselves did not significantly prevent cell death, such findings indicate that survival was promoted by mechanisms that do not require synthesis of RNA or protein. In addition, various lines of experimental evidence (using the kinase inhibitor K-252a or PC 12 cell variants deficient either in protein kinase A activity or in responsiveness to NGF) further suggested that the effective agents maintain survival by independent initial pathways. Regulation of protein kinase activity appears to be a common feature of each pathway and may therefore play a key convergent role in mediating prevention of cell death.
authors.affiliation: Department of Pathology, Columbia University College of Physicians and Surgeons, New York, New York 10032.
authors.forename: A
authors.initials: A
authors.lastname: Rukenstein
authors.forename: R E
authors.initials: RE
authors.lastname: Rydel
authors.forename: L A
authors.initials: LA
authors.lastname: Greene
mesh_terms: D000310:Adrenal Gland Neoplasms / Q000378:metabolism / Q000473:pathology*; D000818:Animals; D001769:Blood; D002227:Carbazoles / Q000494:pharmacology; D002470:Cell Survival; D003470:Culture Media; D026121:Indole Alkaloids; D010673:Pheochromocytoma / Q000378:metabolism / Q000473:pathology*; D014176:Protein Biosynthesis; D011493:Protein Kinase C / Q000037:antagonists & inhibitors; D011494:Protein Kinases / Q000502:physiology; D016283:Proto-Oncogene Proteins p21(ras) / Q000378:metabolism; D012313:RNA / Q000096:biosynthesis / Q000235:genetics; D014158:Transcription, Genetic; D014407:Tumor Cells, Cultured
chemical_list: D002227:Carbazoles; D003470:Culture Media; D026121:Indole Alkaloids; D012313:RNA; C049985:staurosporine aglycone; D011494:Protein Kinases; D011493:Protein Kinase C; D016283:Proto-Oncogene Proteins p21(ras)